Edge Capital Group, LLC Novo Nordisk A S Transaction History

Edge Capital Group, LLC

  • $2.21 Billion
  • Q3 2024

A detailed history of Edge Capital Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Edge Capital Group, LLC holds 57,830 shares of NVO stock, worth $6.08 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
57,830
Previous 59,369 2.59%
Holding current value
$6.08 Million
Previous $8.47 Million 18.75%
% of portfolio
0.31%
Previous 0.42%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$119.07 - $145.42 $183,248 - $223,801
-1,539 Reduced 2.59%
57,830 $6.89 Million
Q2 2024

Aug 13, 2024
SELL
$122.71 - $146.91 $1.53 Million - $1.83 Million
-12,447 Reduced 17.33%
59,369 $8.47 Million
Q1 2024

May 14, 2024
SELL
$102.11 - $135.92 $231,585 - $308,266
-2,268 Reduced 3.06%
71,816 $9.22 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $29,845 - $35,853
-340 Reduced 0.46%
74,084 $7.66 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $3.34 Million - $7.34 Million
36,776 Added 97.68%
74,424 $6.77 Million
Q2 2023

Aug 08, 2023
SELL
$155.98 - $172.65 $149,896 - $165,916
-961 Reduced 2.49%
37,648 $6.09 Million
Q1 2023

May 04, 2023
SELL
$132.34 - $159.14 $493,363 - $593,273
-3,728 Reduced 8.81%
38,609 $6.14 Million
Q4 2022

Feb 07, 2023
SELL
$102.55 - $135.33 $58,863 - $77,679
-574 Reduced 1.34%
42,337 $5.73 Million
Q3 2022

Nov 09, 2022
BUY
$95.28 - $116.93 $10,385 - $12,745
109 Added 0.25%
42,911 $4.28 Million
Q2 2022

Aug 08, 2022
BUY
$103.24 - $121.81 $18,996 - $22,413
184 Added 0.43%
42,802 $4.77 Million
Q1 2022

May 03, 2022
SELL
$93.1 - $112.54 $148,960 - $180,064
-1,600 Reduced 3.62%
42,618 $4.73 Million
Q4 2021

Jan 19, 2022
SELL
$95.88 - $117.08 $456,868 - $557,886
-4,765 Reduced 9.73%
44,218 $4.95 Million
Q3 2021

Oct 26, 2021
SELL
$84.42 - $106.62 $2.06 Million - $2.61 Million
-24,450 Reduced 33.3%
48,983 $4.7 Million
Q2 2021

Aug 09, 2021
SELL
$67.66 - $84.76 $34,506 - $43,227
-510 Reduced 0.69%
73,433 $6.15 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $48,417 - $54,742
722 Added 0.99%
73,943 $4.99 Million
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $298,941 - $345,310
-4,679 Reduced 6.01%
73,221 $5.11 Million
Q3 2020

Nov 09, 2020
BUY
$63.69 - $70.22 $1,210 - $1,334
19 Added 0.02%
77,900 $5.41 Million
Q2 2020

Aug 11, 2020
SELL
$58.54 - $67.94 $1.08 Million - $1.25 Million
-18,407 Reduced 19.12%
77,881 $5.1 Million
Q1 2020

May 08, 2020
BUY
$49.46 - $64.78 $672,853 - $881,267
13,604 Added 16.45%
96,288 $5.8 Million
Q4 2019

Feb 11, 2020
BUY
$49.86 - $58.26 $4.12 Million - $4.82 Million
82,684 New
82,684 $4.79 Million

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Edge Capital Group, LLC Portfolio

Follow Edge Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email